Study of Bosutinib in Japanese Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
Clinical trial NCT03128411 · COMPLETED
Trial details
- NCT number
- NCT03128411
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-15
- Primary completion
- 2019-03-12
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.